{
  "ticker": "JNJ",
  "target_date": "2025-11-24",
  "actual_date": "2025-11-24",
  "collected_at": "2025-12-08T12:34:19.830464",
  "price": {
    "open": 202.42,
    "high": 204.82,
    "low": 201.72,
    "close": 204.75,
    "volume": 14803900,
    "change_1d_pct": 1.05,
    "change_7d_pct": 5.53,
    "change_30d_pct": 7.94
  },
  "technicals": {
    "rsi_14": 94.2,
    "sma_20": 192.13,
    "sma_50": 187.65,
    "macd": 4.345,
    "macd_signal": 3.004,
    "macd_histogram": 1.342,
    "bb_upper": 206.02,
    "bb_lower": 178.24,
    "price_vs_sma20_pct": 6.57,
    "price_vs_sma50_pct": 9.11,
    "volume_ratio": 1.59
  },
  "fundamentals": {
    "market_cap": 488315912192,
    "pe_ratio": 19.563707,
    "forward_pe": 19.120754,
    "price_to_book": 6.151698,
    "price_to_sales": 5.2991996,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.47,
    "pct_from_52w_low": 44.07
  },
  "macro": {
    "spy": {
      "price": 668.73,
      "change_1d_pct": 1.47,
      "change_7d_pct": -0.48
    },
    "vix": {
      "level": 20.52,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.04
    },
    "dollar_index": {
      "level": 100.14
    },
    "gold": {
      "price": 4091.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook",
      "source": "Yahoo",
      "datetime": 1764018900,
      "summary": "Financial foundation toward self-sustained long-term growth established with the closing with HealthCare Royalty (\u201cHCRx\u201d) of a non-dilutive royalty financing valued up to $71 millionProgress in the JNJ-1900 (NBTXR3) global development program announced including first data from a Phase 1 esophageal ",
      "url": "https://finnhub.io/api/news?id=baa9b3a7a74cb529d51e4722223c42150358cbd07331f0249d12ea1b0e942279"
    },
    {
      "headline": "BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study",
      "source": "Yahoo",
      "datetime": 1764010380,
      "summary": "Bayer's asundexian hits key goals in the OCEANIC-STROKE study, showing reduced ischemic stroke risk without added major bleeding.",
      "url": "https://finnhub.io/api/news?id=a86b638861283060b6432a94a6e9f81316f65a0de3e8af4dc0b33167941fec12"
    },
    {
      "headline": "EXCLUSIVE: Sustainable Value Creation: Keynote Fireside with Trian Fund Management, 5th Palm Beach CorpGov Forum",
      "source": "Yahoo",
      "datetime": 1764005834,
      "summary": "CorpGov and IPO Edge are pleased to provide complete video coverage of the fifth annual Palm Beach CorpGov Forum held on Nov. 5-6, featuring keynote speaker Josh Frank, Partner and Co-Chief Investment Officer at Wall Street legend Nelson Peltz\u2019s Trian Fund Management. Mr. Frank discussed Trian\u2019s pos",
      "url": "https://finnhub.io/api/news?id=4819a48b2ba070226c10c60fdb7df4b0349fee023bf3422fcf8fbc2a8cc2d3d2"
    },
    {
      "headline": "Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts",
      "source": "Yahoo",
      "datetime": 1763999760,
      "summary": "The Hip Replacement industry is poised for substantial growth, projected to reach US$ 10.24 billion by 2033, up from US$ 6.92 billion in 2024, at a CAGR of 4.45% between 2025 and 2033. This expansion is driven by increased awareness of procedures such as hip arthroplasty, which helps alleviate disco",
      "url": "https://finnhub.io/api/news?id=264f9bb36cc60f0e70bd5b5eee25b01543ea5c4fe703943e5fdbb84c1b759d2e"
    },
    {
      "headline": "Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue",
      "source": "Yahoo",
      "datetime": 1763998140,
      "summary": "It has grown wildly, and it could keep growing.",
      "url": "https://finnhub.io/api/news?id=335bc11b5a3bd859a2576f4f750a0c759d82c762772486b6b575c99289bc991d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-14",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/xslF345X05/ownership.xml"
    },
    {
      "form": "13F-HR",
      "date": "2025-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000587/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-11-10",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}